Subject: : To participate in cross sectional survey to understand disease perceptive and management practices of irritable bowel syndrome (IBS) amongst Indian health care professionals
IBS is one of the most common functional gastrointestinal (GI) disorders seen in clinical practice. IBS is characterized by chronic or recurrent abdominal pain related to defecation, associated with change in frequency or form of stool. IBS subtypes include diarrheapredominant, constipation-predominant, and mixed presentation with alternating diarrhea and constipation
Symptoms of IBS are often difficult to quantify objectively. The complexity and diversity of IBS presentation makes treatment difficult. The etiology of IBS is poorly understood and many factors are involved in IBS etiology. Also, the pathophysiology of IBS is not clear. Many theories have been put forward, but the exact cause of IBS is still uncertain. Across the IBS subtypes, the presentation of symptoms may vary among patients and change over time.
No specific treatment options for IBS are available. In clinical practice, the decision to treat is up to the discretion of the physician. Despite the high prevalence of this condition, only about 30% of patients with IBS seek the advice of a physician for evaluation and treatment. Accurate and timely diagnosis, together with the appropriate intervention, are critical for optimal management of IBS. IBS is associated with substantial costs to patients, healthcare systems and society. Therefore, appropriate diagnosis and effective treatment for IBS is necessary.
Current approaches to diagnosis of IBS start with the identification of symptoms and the exclusion of organic disease in patients with “red-flags”. The treatment consists of lifestyle and dietary modification. Biofeedback and psychotherapeutic intervention can also be used for management of IBS. Pharmacological options are usually recommended if nonpharmacological methods alone have proven to be ineffective. Most of the current pharmacological therapies aim at treating the symptoms with the rationale of modulating intestinal motility and/or secretion, decreasing visceral sensitivity or treating associated disorders, such are anxiety and/or depression.
There is limited evidence on the disease perspective and management practices of irritable bowel syndrome among HCPs in India. Therefore, this multicentric survey is designed to understand the disease perspective and management practices of irritable bowel syndrome in routine clinical practice among HCPs in India
If you agree to participate, you will need to provide assessment response, on to the standard questionnaire form. A link will be provided for the same on your registered email address. We trust you and we are partners in safe and effective drug therapy. In that spirit we hope you will consent to participate in this survey.
|
}}){kind=logo}
}})